Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

(2021) Kevin R. McCarthy et al.   SCIENCE

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

(2020) Erica J. Brenner et al.   GASTROENTEROLOGY

Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study

(2020) Nabeel Khan et al.   GASTROENTEROLOGY

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

(2020) Nicholas A Kennedy et al.   GUT

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

(2020) Marc Feldmann et al.   LANCET

Real-time tracking of self-reported symptoms to predict potential COVID-19

(2020) Cristina Menni et al.   NATURE MEDICINE

Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2

(2020) Peter Muench et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Effect of IBD medications on COVID-19 outcomes: results from an international registry

(2020) Ryan C Ungaro et al.   GUT

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

(2020) Victoria A. Avanzato et al.   CELL

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

(2020) Bina Choi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The REDCap consortium: Building an international community of software platform partners

(2019) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017

(2019) Saeid Safiri et al.   ANNALS OF THE RHEUMATIC DISEASES

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Sudabeh Alatab et al.   Lancet Gastroenterology & Hepatology

Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy

(2018) Perry K Pratt et al.   INFLAMMATORY BOWEL DISEASES

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

(2015) V. Jairath et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

(2014) R. Khanna et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease

(2013) Millie D Long et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-Control questionnaire

(2013) Keith Bodger et al.   GUT

Anti-TNF treatment blocks the induction of T cell-dependent humoral responses

(2012) Gabriela Franco Salinas et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease

(2009) Gil Y Melmed et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The PHQ-8 as a measure of current depression in the general population

(2008) Kurt Kroenke et al.   JOURNAL OF AFFECTIVE DISORDERS